We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIII icon
1726
G-III Apparel Group
GIII
$1.43B
$2.64M ﹤0.01%
117,864
-2,820
-2% -$71.1K
NX icon
1727
Quanex
NX
$960M
$2.64M ﹤0.01%
139,680
+2,505
+2% +$44.4K
ATRC icon
1728
AtriCure
ATRC
$2.24B
$2.64M ﹤0.01%
80,447
+9,528
+13% +$310K
PHR icon
1729
Phreesia
PHR
$762M
$2.64M ﹤0.01%
92,594
+5,750
+7% +$146K
BOKF icon
1730
BOK Financial
BOKF
$8.88B
$2.63M ﹤0.01%
26,937
-1,326
-5% -$125K
WGO icon
1731
Winnebago Industries
WGO
$894M
$2.63M ﹤0.01%
90,571
-1,081
-1% -$35.4K
THRM icon
1732
Gentherm
THRM
$1.35B
$2.62M ﹤0.01%
92,587
+1,173
+1% +$31.1K
RXRX icon
1733
Recursion Pharmaceuticals
RXRX
$1.7B
$2.62M ﹤0.01%
517,255
+158,080
+44% +$777K
FUTU icon
1734
Futu Holdings
FUTU
$14.7B
$2.61M ﹤0.01%
21,115
-1,433
-6% -$147K
ARQT icon
1735
Arcutis Biotherapeutics
ARQT
$3.26B
$2.61M ﹤0.01%
186,099
+5,025
+3% +$70.4K
SMMT icon
1736
Summit Therapeutics
SMMT
$10.7B
$2.6M ﹤0.01%
122,394
-9,366
-7% -$214K
UPWK icon
1737
Upwork
UPWK
$1.05B
$2.6M ﹤0.01%
193,199
+10,539
+6% +$151K
NCNO icon
1738
nCino
NCNO
$2.24B
$2.59M ﹤0.01%
92,770
+2,961
+3% +$74K
INDV icon
1739
Indivior Pharmaceuticals
INDV
$4.57B
$2.59M ﹤0.01%
+175,989
New +$2.05M
ALHC icon
1740
Alignment Healthcare
ALHC
$2.91B
$2.59M ﹤0.01%
184,683
+43,045
+30% +$693K
SHG icon
1741
Shinhan Financial Group
SHG
$35.4B
$2.58M ﹤0.01%
57,190
-9,065
-14% -$345K
HTZ icon
1742
Hertz
HTZ
$795M
$2.58M ﹤0.01%
377,826
+26,079
+7% +$163K
BEAM icon
1743
Beam Therapeutics
BEAM
$2.74B
$2.57M ﹤0.01%
151,372
+10,168
+7% +$177K
APOG icon
1744
Apogee Enterprises
APOG
$885M
$2.57M ﹤0.01%
63,399
+386
+0.6% +$15.9K
NTST
1745
NETSTREIT Corp
NTST
$2.1B
$2.56M ﹤0.01%
151,078
+18,278
+14% +$293K
ITUB icon
1746
Itaú Unibanco
ITUB
$80.8B
$2.55M ﹤0.01%
387,220
+45,802
+13% +$279K
WGS icon
1747
GeneDx Holdings
WGS
$2.31B
$2.55M ﹤0.01%
27,610
+8,258
+43% +$648K
MCRI icon
1748
Monarch Casino & Resort
MCRI
$2.23B
$2.55M ﹤0.01%
29,483
-42
-0.1% -$3.39K
SAFE
1749
Safehold
SAFE
$1.08B
$2.55M ﹤0.01%
163,746
+9,696
+6% +$151K
FBRT
1750
Franklin BSP Realty Trust
FBRT
$670M
$2.55M ﹤0.01%
238,165
+216
+0.1% +$2.43K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.